Photo by Google DeepMind on Pexels

The pharmaceutical industry faces a persistent challenge: a high failure rate in traditional drug development. To combat this, a growing number of startups are harnessing the capabilities of artificial intelligence. These companies believe sophisticated AI algorithms can identify promising drug candidates, leading to the creation of innovative, life-saving therapies and significantly improving overall success rates within the pharma sector. The promise is that AI can sift through vast datasets, predict drug efficacy, and ultimately revolutionize how new medicines are discovered and brought to market.